LNA-G (dmf) CNA CPG Low Bulk Density
CPG for incorporation of a locked nucleic acid G analogue at the 3' end of an oligonucleotide.
CPG for incorporation of a locked nucleic acid G analogue at the 3' end of an oligonucleotide.
CPG for the incorporation of a locked nucleic acid 5-Me C analogue at the 3' end of an oligonucleotide.
Phosphoramidite for N-Acetylgalactosamine (GalNAc) incorporation in an oligonucleotide.
CPG column for incorporation of GalNAc at 3' end of an oligonucleotide, with a dR spacer
CPG for incorporation of GalNAc at 3' end of an oligonucleotide, with a dR spacer
CPG used to add a trivalent GalNAc ligand to the 3' end of an oligonucleotide.
CPG for incorporation of unmodified inosine at 3' end of an oligonucleotide.
CPG for the incorporation of an abasic spacer at the 3' end of an oligonucleotide.
CPG for the incorporation of an inverse (5' to 3') abasic (no nucleobase on the sugar) within an oligonucleotide.
Monomer used to incorporate a T (U) nucleobase analogue in peptide nucleic acid synthesis.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |